BlackRock Health Sciences Term Trust (NYSE:BMEZ) Shares Down 1% – Time to Sell?

Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) were down 1% during mid-day trading on Wednesday . The stock traded as low as $15.52 and last traded at $15.59. 123,896 shares traded hands during mid-day trading, a decline of 47% from the average session volume of 234,323 shares. The stock had previously closed at $15.74.

BlackRock Health Sciences Term Trust Trading Down 1.0%

The stock has a fifty day moving average of $14.54 and a 200 day moving average of $14.71.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be given a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a c) annualized dividend and a dividend yield of 8.5%.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

Several institutional investors have recently added to or reduced their stakes in BMEZ. Kestra Advisory Services LLC purchased a new stake in BlackRock Health Sciences Term Trust during the fourth quarter worth about $26,000. SouthState Bank Corp bought a new stake in BlackRock Health Sciences Term Trust in the first quarter worth about $29,000. PNC Financial Services Group Inc. purchased a new position in BlackRock Health Sciences Term Trust in the first quarter valued at about $35,000. Geneos Wealth Management Inc. purchased a new position in BlackRock Health Sciences Term Trust in the first quarter valued at about $40,000. Finally, Allworth Financial LP grew its position in shares of BlackRock Health Sciences Term Trust by 24,584.6% during the 3rd quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock valued at $46,000 after acquiring an additional 3,196 shares during the period.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.